| Breakdown | TTM | Jun 2025 | Jun 2024 | Jun 2023 | Jun 2022 | Jun 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 101.34M | 103.50M | 109.09M | 89.72M | 55.60M | 42.52M |
| Gross Profit | 18.57M | 33.39M | 33.97M | 6.83M | 3.69M | 1.37M |
| EBITDA | 3.28M | 5.91M | 7.65M | 4.11M | 1.13M | 1.88M |
| Net Income | -2.95M | -878.00K | 2.17M | -339.00K | -616.00K | 3.45M |
Balance Sheet | ||||||
| Total Assets | 71.24M | 75.23M | 72.01M | 67.37M | 71.16M | 56.15M |
| Cash, Cash Equivalents and Short-Term Investments | 7.52M | 9.68M | 9.43M | 7.73M | 14.06M | 7.01M |
| Total Debt | 6.61M | 6.26M | 5.13M | 3.48M | 2.90M | 5.13M |
| Total Liabilities | 23.81M | 25.18M | 21.78M | 19.35M | 22.32M | 24.54M |
| Stockholders Equity | 47.43M | 50.05M | 50.24M | 48.02M | 48.84M | 31.61M |
Cash Flow | ||||||
| Free Cash Flow | -2.13M | 785.00K | 4.48M | 522.00K | -3.83M | -1.92M |
| Operating Cash Flow | -1.00K | 2.87M | 6.48M | 4.81M | -1.31M | -1.32M |
| Investing Cash Flow | 366.00K | -2.35M | -3.71M | -8.39M | -6.65M | -2.49M |
| Financing Cash Flow | -3.31M | -390.00K | -1.06M | -2.83M | 14.99M | 6.34M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
61 Neutral | $10.43B | 7.12 | -0.05% | 2.87% | 2.86% | -36.73% | |
55 Neutral | AU$37.70M | -5.61 | -67.76% | ― | 7.08% | 33.70% | |
52 Neutral | AU$24.82M | -6.91 | -63.81% | ― | ― | 52.66% | |
46 Neutral | AU$240.37M | -4.85 | -22.28% | ― | 16.47% | 29.53% | |
45 Neutral | AU$46.57M | -15.81 | -1.75% | ― | -5.37% | -140.00% | |
41 Neutral | AU$25.64M | -1.58 | -869.14% | ― | 340.27% | 19.44% | |
37 Underperform | AU$25.02M | -2.44 | -263.52% | ― | -32.85% | 28.00% |
SciDev Ltd has disclosed a change in director Dan O’Toole’s relevant interest in the company’s securities, reflecting an increase in his indirect shareholding through Huon Road Pty Ltd
The on-market purchase signals a higher personal financial exposure by the director to SciDev’s equity, which may be interpreted by investors as a sign of confidence in the company’s prospects. The transaction occurred outside a closed period and required no special trading clearance, indicating that it was conducted under normal trading conditions within the company’s governance framework.
The most recent analyst rating on (AU:SDV) stock is a Hold with a A$0.23 price target. To see the full list of analyst forecasts on SciDev Ltd stock, see the AU:SDV Stock Forecast page.
SciDev Ltd reported a challenging first half of FY26, with revenue slipping to $47.9 million from $49.9 million a year earlier and gross margins contracting to 28%. Management attributed the weaker performance primarily to disruption in fracturing schedules within its Energy Services division and higher costs in its Overseas Water Technologies operations, which reduced reported EBITDA to $0.4 million and underlying EBITDA to $1.1 million, despite maintaining a net cash position of $4.4 million and 54% of revenue from recurring sources.
The results underscore operational headwinds in key business lines but also highlight the resilience provided by the company’s recurring revenue base and net cash position. Investors will focus on how effectively SciDev can stabilise costs in its overseas operations and restore growth in Energy Services activity to support a recovery in margins and earnings over the remainder of the financial year.
The most recent analyst rating on (AU:SDV) stock is a Hold with a A$0.35 price target. To see the full list of analyst forecasts on SciDev Ltd stock, see the AU:SDV Stock Forecast page.
SciDev reported a weaker first half of FY26, with revenue slipping to A$47.9 million and underlying EBITDA falling to A$1.1 million, as a frac schedule change at a key U.S. energy customer hit xSlik® sales and international Water Technologies investments outpaced revenues. In response, the company is shifting its international water business to a lower-cost channel partner model, diversifying its Energy Services customer base, and capitalising on record Process Chemistry results and a profitable APAC Water Technologies arm to drive second-half revenue and earnings growth.
Management has highlighted improving quarterly momentum, cost reductions at corporate level, and a strategy to expand higher-margin and recurring revenue streams, which now account for more than half of group sales. These moves, alongside R&D for next-generation specialty chemicals and cross-selling water technologies across its global customer base, aim to strengthen SciDev’s competitive position as it pursues its ambition to be a leading water technology provider to the energy and mining sectors.
The most recent analyst rating on (AU:SDV) stock is a Hold with a A$0.35 price target. To see the full list of analyst forecasts on SciDev Ltd stock, see the AU:SDV Stock Forecast page.
SciDev Limited reported half-year revenues of $47.9 million for the period ended 31 December 2025, down 4% from a year earlier, while its net loss after tax widened sharply to $2.14 million from $68,000. The result pushed basic and diluted earnings per share to a loss of 1.13 cents, compared with a 0.04 cent loss previously, and the company again did not declare a dividend.
The deterioration in earnings, despite only a modest decline in revenue, points to rising costs, margin pressure or one-off impacts weighing on profitability during the half. Net tangible assets per share also eased to 12.16 cents from 13.32 cents at 30 June 2025, suggesting a slight weakening in balance sheet backing for shareholders and underscoring a more challenging operating environment.
The most recent analyst rating on (AU:SDV) stock is a Hold with a A$0.35 price target. To see the full list of analyst forecasts on SciDev Ltd stock, see the AU:SDV Stock Forecast page.
SciDev Ltd will release its first-half FY26 financial results before the market opens on 26 February 2026 and will host an investor webcast the same morning. The online briefing, led by Managing Director and CEO Seán Halpin and CFO Todd Scott, will outline the company’s 1H FY26 operational highlights and business activities and include a Q&A session for investors and shareholders.
The event underscores SciDev’s efforts to maintain active engagement with the market as it advances its portfolio of water treatment technologies across resource and infrastructure industries. Stakeholders will be looking to the presentation for insights into trading performance, project momentum and how its solutions are being adopted to address water reuse, efficiency and environmental challenges in key industrial sectors.
The most recent analyst rating on (AU:SDV) stock is a Hold with a A$0.35 price target. To see the full list of analyst forecasts on SciDev Ltd stock, see the AU:SDV Stock Forecast page.
SciDev named BDO Audit as its new external auditor after a competitive tender and ASIC-approved resignation of Ernst & Young, noting no disagreements with the outgoing firm. The board expects BDO to serve through the 2026 AGM, reinforcing governance stability and signaling continuity in financial oversight ahead of the next reappointment vote.
The most recent analyst rating on (AU:SDV) stock is a Hold with a A$0.39 price target. To see the full list of analyst forecasts on SciDev Ltd stock, see the AU:SDV Stock Forecast page.
SciDev Ltd has announced a change in the director’s interest, with Johannes Risseeuw acquiring 70,000 fully paid ordinary shares through an on-market purchase at an average price of $0.43 per share. This acquisition reflects a strategic move by the director, potentially indicating confidence in the company’s future performance and stability, which may influence stakeholder perceptions and market positioning.
The most recent analyst rating on (AU:SDV) stock is a Hold with a A$0.50 price target. To see the full list of analyst forecasts on SciDev Ltd stock, see the AU:SDV Stock Forecast page.
SciDev Ltd has announced a change in the director’s interest, with Director Mike Utsler acquiring 55,000 fully paid ordinary shares through an on-market purchase at an average price of $0.44 per share. This acquisition increases his total shareholding to 117,111 shares, reflecting a significant personal investment in the company, which could indicate confidence in SciDev’s future performance and strategic direction.
The most recent analyst rating on (AU:SDV) stock is a Hold with a A$0.50 price target. To see the full list of analyst forecasts on SciDev Ltd stock, see the AU:SDV Stock Forecast page.